Doctor Christin Bexelius has since 2015 been leading payer related activities to support Roche’s phase III clinical trial programs in Basel, Switzerland. Through her work she has been working close with both internal and external stakeholders in relation to access and policy, including academia, policy makers and other pharma industry. Recently she has been leading workstreams in the European based project IMI ROADMAP aiming at mapping real world data on Alzheimer’s disease. Doctor Bexelius has been working as a health economist in Alzheimer’s disease since 2010 and holds a PhD in epidemiology.